Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
VCYT	VERACYTE INC	$32.79	-0.46%	-1.47%	-8.20%	-22.83%	-0.09%	-2.67%	49.66%	-34.43%	530.58%	$50.71	$22.61	35.34%	45.02%	1.90	586,000	-37.99%
PHAR	PHARMING GROUP NV	$16.23	1.63%	6.36%	-3.39%	-8.82%	9.66%	86.10%	32.38%	30.47%	N/A	$21.34	$7.50	23.95%	116.34%	0.57	13,500	-81.51%
JAZZ	JAZZ PHARMACEUTICALS PLC	$189.08	2.20%	4.78%	-3.94%	10.91%	47.95%	39.80%	31.90%	13.45%	60.06%	$197.60	$95.49	4.31%	98.01%	0.70	821,000	-44.41%
INVA	INNOVIVA INC	$22.59	3.06%	3.20%	-6.81%	14.09%	21.65%	29.98%	98.51%	93.41%	93.91%	$25.15	$16.52	10.16%	36.74%	0.40	568,000	-21.98%
AUPH	AURINIA PHARMACEUTICALS INC	$14.37	1.13%	2.06%	-0.42%	-11.57%	11.83%	65.74%	32.81%	14.46%	374.26%	$16.54	$6.83	13.12%	110.55%	1.11	858,000	-42.07%
BCRX	BIOCRYST PHARMACEUTICALS INC	$9.40	-2.69%	2.62%	24.50%	23.20%	22.88%	16.48%	11.11%	-12.23%	240.58%	$11.31	$6.00	16.89%	56.67%	1.11	7,730,000	-30.65%
PBYI	PUMA BIOTECHNOLOGY INC	$6.33	1.12%	5.50%	-17.58%	2.76%	34.68%	94.77%	165.97%	-37.39%	-82.10%	$7.68	$2.58	17.58%	145.83%	0.98	211,000	-14.23%
EXEL	EXELIXIS INC	$42.79	2.92%	3.70%	-4.39%	-7.47%	10.58%	13.46%	129.29%	94.04%	1,037.90%	$49.62	$32.38	13.77%	32.13%	0.60	1,832,000	-22.57%
ASMB	ASSEMBLY BIOSCIENCES INC	$28.67	1.56%	4.18%	-2.28%	-14.72%	12.30%	151.05%	143.34%	-46.43%	-52.31%	$39.71	$7.75	27.79%	269.94%	0.90	58,000	-17.14%
XERS	XERIS BIOPHARMA HOLDINGS INC	$5.30	0.19%	-2.39%	-20.42%	-28.09%	-32.48%	-9.71%	317.32%	22.40%	N/A	$10.08	$3.81	47.42%	39.29%	1.23	2,342,000	23.92%
TBPH	THERAVANCE BIOPHARMA INC	$15.29	2.62%	10.56%	-19.78%	-18.84%	10.88%	64.23%	41.71%	-23.59%	-11.67%	$21.03	$7.90	27.29%	93.54%	0.62	551,000	-11.98%
ANAB	ANAPTYSBIO INC	$65.39	3.76%	1.04%	18.65%	30.52%	196.69%	254.61%	198.58%	209.61%	N/A	$68.39	$15.40	4.39%	324.61%	0.88	278,000	24.11%
RPRX	ROYALTY PHARMA PLC	$47.03	3.20%	2.71%	4.16%	19.91%	34.76%	39.31%	25.78%	9.81%	N/A	$47.86	$29.66	1.73%	58.56%	0.47	3,268,000	53.00%
MDXG	MIMEDX GROUP INC	$4.10	-0.73%	-3.30%	-22.35%	-40.58%	-41.26%	-48.10%	20.23%	-58.33%	-49.69%	$7.99	$4.07	48.69%	0.64%	1.29	573,000	-20.64%
VRTX	VERTEX PHARMACEUTICALS INC	$454.97	1.42%	0.75%	-5.81%	-1.71%	19.14%	-10.62%	47.49%	114.24%	478.11%	$510.77	$362.50	10.92%	25.51%	0.57	1,174,000	2.44%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$22.74	4.17%	2.25%	-15.81%	-21.51%	35.92%	32.90%	120.56%	-19.33%	N/A	$31.77	$11.86	28.42%	91.74%	1.18	788,000	4.23%
VCEL	VERICEL CORP	$31.44	-4.96%	-2.66%	-15.23%	-16.52%	5.36%	-34.45%	8.12%	-42.11%	487.66%	$46.72	$29.24	32.71%	7.52%	1.48	2,017,000	255.11%
CGEN	COMPUGEN LTD	$2.06	-0.48%	-5.07%	17.05%	33.77%	49.28%	31.21%	184.14%	-75.56%	-63.02%	$2.38	$1.13	13.45%	82.30%	1.68	120,000	-12.41%
ONC	BEONE MEDICINES LTD	$283.45	2.81%	0.41%	-19.53%	-9.26%	-13.77%	13.17%	26.10%	-13.72%	948.65%	$385.22	$196.45	26.42%	44.29%	0.97	160,000	-23.44%
SLGL	SOL-GEL TECHNOLOGIES LTD	$79.07	-1.17%	4.95%	-12.26%	88.94%	182.49%	1,314.49%	90.07%	-31.95%	N/A	$97.97	$4.02	19.29%	1,867.89%	0.51	67,500	20.54%
LCTX	LINEAGE CELL THERAPEUTICS INC	$1.55	4.73%	3.33%	-18.42%	-6.06%	0.00%	200.97%	11.51%	-32.31%	-38.74%	$2.09	$0.37	25.84%	324.66%	1.13	1,574,000	61.27%
TVTX	TRAVERE THERAPEUTICS INC	$27.56	2.87%	2.23%	-6.07%	-30.47%	12.01%	31.18%	27.36%	15.56%	123.52%	$42.13	$12.91	34.58%	113.48%	1.12	1,105,000	32.49%
ADMA	ADMA BIOLOGICS INC	$9.63	-15.00%	-35.24%	-38.58%	-50.05%	-37.14%	-52.37%	190.06%	369.76%	24.58%	$25.67	$8.62	62.49%	11.72%	1.23	32,419,000	42.76%
STTK	SHATTUCK LABS INC	$6.37	4.08%	5.46%	57.28%	90.15%	178.17%	435.29%	112.33%	-79.89%	N/A	$6.59	$0.69	3.34%	820.52%	1.38	631,000	85.59%
XLO	XILIO THERAPEUTICS INC	$8.53	1.91%	12.24%	12.09%	-7.95%	-19.75%	-19.83%	-79.89%	N/A	N/A	$16.52	$6.47	48.37%	31.94%	0.93	44,600	-38.90%
INCY	INCYTE CORP	$92.23	1.78%	-0.01%	-7.75%	-7.87%	12.94%	48.57%	30.25%	15.61%	34.74%	$112.29	$53.56	17.86%	72.20%	0.54	1,019,000	-35.67%
LQDA	LIQUIDIA CORP	$36.61	4.01%	-0.05%	22.03%	6.39%	63.07%	134.68%	432.90%	1,297.33%	N/A	$46.67	$11.26	21.56%	225.13%	1.03	1,017,000	60.66%
CPRX	CATALYST PHARMACEUTICALS INC	$23.80	3.16%	4.34%	-4.26%	-2.26%	24.41%	-7.47%	44.77%	431.25%	1,916.95%	$26.58	$19.05	10.46%	24.93%	1.03	982,000	22.75%
FENC	FENNEC PHARMACEUTICALS INC	$6.17	2.49%	-17.40%	-30.44%	-23.73%	-29.08%	-4.04%	-24.85%	-6.52%	244.69%	$9.92	$4.68	37.80%	31.84%	0.65	372,000	-54.02%
NAGE	NIAGEN BIOSCIENCE INC	$4.52	-0.44%	-0.66%	-15.20%	-31.93%	-51.97%	-39.89%	182.50%	-49.78%	6.10%	$14.69	$4.39	69.23%	2.96%	1.51	657,000	-14.45%
FBIO	FORTRESS BIOTECH INC	$2.99	2.40%	-5.38%	-15.77%	-20.05%	-20.27%	70.86%	-73.42%	-94.63%	-93.33%	$4.53	$1.33	34.00%	125.66%	1.19	412,000	22.26%
AGEN	AGENUS INC	$3.56	0.00%	-5.32%	10.22%	7.55%	-8.72%	113.17%	-88.59%	-93.69%	-95.38%	$7.34	$1.38	51.50%	157.97%	1.75	255,000	-32.72%
SLNO	SOLENO THERAPEUTICS INC	$31.84	1.60%	-2.93%	-22.36%	-33.18%	-49.23%	-36.38%	1,243.46%	68.47%	-64.62%	$90.32	$30.11	64.75%	5.75%	0.39	1,250,000	-42.13%
TARS	TARSUS PHARMACEUTICALS INC	$66.96	6.03%	-1.88%	-7.83%	-18.12%	20.89%	30.45%	450.21%	119.54%	N/A	$85.25	$38.51	21.45%	73.88%	0.89	406,000	21.19%
ALNY	ALNYLAM PHARMACEUTICALS INC	$328.70	6.70%	4.42%	0.41%	-17.95%	-26.89%	16.99%	72.54%	143.05%	459.20%	$495.55	$205.87	33.67%	59.66%	0.89	1,100,000	-26.42%
RIGL	RIGEL PHARMACEUTICALS INC	$26.29	0.61%	3.34%	-24.06%	-40.26%	-8.40%	39.03%	97.67%	-27.17%	27.00%	$52.24	$15.50	49.67%	69.61%	1.28	220,000	-24.91%
XOMA	XOMA ROYALTY CORP	$30.20	3.35%	10.42%	12.94%	15.89%	-15.43%	45.61%	43.60%	-9.06%	107.93%	$39.92	$18.35	24.35%	64.56%	0.80	101,000	14.77%
IBRX	IMMUNITYBIO INC	$8.07	8.83%	-5.72%	-15.41%	277.10%	228.05%	194.53%	371.93%	-73.88%	-6.27%	$12.43	$1.83	35.08%	340.98%	2.16	28,786,000	-66.76%
ENTA	ENANTA PHARMACEUTICALS INC	$12.17	0.75%	-4.17%	-16.87%	-27.77%	57.03%	106.97%	-69.44%	-75.81%	-55.03%	$17.15	$4.09	29.04%	197.56%	1.01	145,000	27.19%
ZVRA	ZEVRA THERAPEUTICS INC	$9.13	-0.22%	-4.40%	2.24%	2.93%	-4.10%	12.02%	67.83%	-4.99%	-96.11%	$13.16	$6.19	30.62%	47.50%	0.88	615,000	-7.38%
SPRO	SPERO THERAPEUTICS INC	$2.41	1.69%	-2.03%	8.56%	3.88%	24.23%	168.08%	70.92%	-83.23%	N/A	$3.22	$0.51	25.16%	377.23%	0.74	186,000	-52.91%
REGN	REGENERON PHARMACEUTICALS INC	$749.47	1.05%	0.72%	-4.44%	-4.52%	34.92%	18.19%	-8.65%	61.70%	105.98%	$821.11	$476.49	8.72%	57.29%	0.60	470,000	-7.48%
NBP	NOVABRIDGE BIOSCIENCES	$2.64	4.76%	-6.38%	-19.51%	-39.17%	-25.00%	203.45%	-14.29%	-94.40%	N/A	$6.79	$0.60	61.12%	343.70%	1.32	887,000	-22.67%
NRXP	NRX PHARMACEUTICALS INC	$2.41	13.15%	26.84%	26.18%	-5.86%	-17.18%	19.90%	-66.86%	-99.10%	N/A	$3.84	$1.58	37.24%	52.53%	1.07	2,583,000	63.69%
VIR	VIR BIOTECHNOLOGY INC	$8.99	4.90%	-3.54%	-10.10%	49.83%	73.55%	29.35%	-60.93%	-82.94%	N/A	$10.94	$4.16	17.82%	116.37%	1.29	2,435,000	40.91%
HALO	HALOZYME THERAPEUTICS INC	$63.24	1.93%	-0.64%	-10.11%	-8.17%	-14.51%	-2.47%	77.14%	53.12%	630.25%	$82.22	$47.50	23.08%	33.14%	0.80	856,000	-29.49%
ADCT	ADC THERAPEUTICS SA	$3.97	0.76%	-1.00%	-7.03%	13.11%	15.07%	145.06%	100.51%	-84.97%	N/A	$4.98	$1.05	20.28%	278.10%	1.45	523,000	47.74%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$45.84	2.00%	1.53%	7.20%	9.14%	29.09%	97.67%	303.52%	174.82%	N/A	$49.12	$18.26	6.68%	151.11%	0.81	364,000	-5.94%
BMRN	BIOMARIN PHARMACEUTICAL INC	$55.59	2.77%	0.29%	-9.52%	-7.27%	5.64%	-22.28%	-39.25%	-25.64%	-29.63%	$73.18	$50.76	24.04%	9.52%	0.72	1,947,000	18.07%
EVAX	EVAXION A	$3.70	0.68%	-2.12%	9.79%	-27.88%	-18.32%	111.43%	-93.88%	-98.87%	N/A	$12.15	$1.20	69.55%	208.33%	0.61	10,000	-45.36%
TECH	BIO-TECHNE CORP	$52.69	0.50%	3.70%	-8.95%	-11.03%	4.38%	-12.15%	-28.23%	-44.13%	126.67%	$72.16	$46.01	26.98%	14.52%	1.17	1,586,000	-10.80%
LGND	LIGAND PHARMACEUTICALS INC	$204.56	1.44%	-2.37%	6.88%	4.46%	22.67%	86.49%	190.94%	33.08%	99.53%	$227.92	$93.58	10.25%	118.59%	1.14	137,000	-32.18%
NBTX	NANOBIOTIX SA	$30.63	4.65%	-6.19%	18.72%	32.94%	107.66%	756.78%	787.83%	100.52%	N/A	$41.89	$2.99	26.88%	925.79%	1.03	103,000	53.73%
QTTB	Q32 BIO INC	$7.25	-0.68%	24.78%	53.28%	126.56%	285.64%	248.56%	-57.60%	-95.78%	N/A	$7.80	$1.35	7.05%	439.03%	1.08	244,000	-12.23%
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$14.15	1.80%	6.55%	-12.71%	-15.27%	7.77%	68.05%	62.27%	-63.42%	N/A	$20.76	$6.68	31.84%	111.99%	2.03	2,117,000	24.24%
KRYS	KRYSTAL BIOTECH INC	$254.95	3.18%	1.64%	-6.44%	1.10%	58.21%	32.58%	220.57%	258.13%	N/A	$298.30	$122.80	14.53%	107.61%	1.32	238,000	-12.50%
ORMP	ORAMED PHARMACEUTICALS INC	$3.50	2.34%	-1.96%	-6.17%	18.64%	45.83%	50.21%	62.04%	-66.05%	-45.90%	$3.76	$1.82	6.91%	92.31%	1.21	83,000	-52.57%
CYPH	CYPHERPUNK TECHNOLOGIES INC	$0.74	0.54%	3.63%	8.47%	-38.08%	114.74%	91.49%	-74.39%	-96.36%	N/A	$3.70	$0.22	79.92%	234.68%	1.45	811,000	-56.58%
ASND	ASCENDIS PHARMA A	$220.90	2.49%	-2.86%	-3.11%	5.70%	16.42%	37.17%	103.48%	68.13%	1,126.54%	$248.58	$124.06	11.14%	78.06%	0.70	292,000	14.96%
DTIL	PRECISION BIOSCIENCES INC	$6.47	1.09%	-7.97%	57.80%	52.96%	31.24%	27.11%	-70.85%	-97.89%	N/A	$8.82	$3.53	26.64%	83.29%	1.28	211,000	-27.74%
ABUS	ARBUTUS BIOPHARMA CORP	$4.53	5.10%	6.59%	-1.52%	-5.23%	4.86%	34.42%	48.04%	35.22%	18.90%	$5.10	$2.71	11.18%	67.47%	0.93	2,547,000	63.69%
ARGX	ARGENX SE	$697.05	2.89%	1.79%	-14.68%	-17.50%	-1.97%	15.12%	92.64%	137.54%	N/A	$934.62	$510.06	25.42%	36.66%	0.64	406,000	58.59%
AXSM	AXSOME THERAPEUTICS INC	$161.78	1.91%	2.48%	-1.49%	6.40%	39.45%	34.41%	153.10%	172.72%	1,885.03%	$191.50	$86.99	15.52%	85.98%	0.89	435,000	-65.26%
MRNA	MODERNA INC	$53.54	4.29%	2.18%	4.22%	71.60%	117.55%	58.17%	-63.91%	-59.84%	N/A	$59.55	$22.28	10.09%	140.31%	1.32	4,424,000	-7.79%
UTHR	UNITED THERAPEUTICS CORP	$541.60	1.84%	2.12%	1.21%	6.79%	27.31%	71.00%	148.43%	221.71%	399.31%	$549.50	$266.98	1.44%	102.86%	0.44	529,000	-2.04%
ACAD	ACADIA PHARMACEUTICALS INC	$22.01	5.01%	8.32%	-11.85%	-20.31%	3.77%	28.64%	18.33%	-15.41%	-7.56%	$28.35	$13.40	22.36%	64.25%	0.97	2,286,000	24.31%
ALMS	ALUMIS INC	$24.81	7.54%	-2.40%	-15.58%	126.16%	521.80%	520.25%	N/A	N/A	N/A	$30.60	$2.76	18.92%	798.91%	0.78	1,844,000	76.12%
MIRM	MIRUM PHARMACEUTICALS INC	$90.17	2.61%	-1.63%	-16.99%	13.76%	22.56%	91.61%	283.70%	393.27%	N/A	$109.28	$36.88	17.49%	144.50%	0.71	488,000	-44.86%
KZIA	KAZIA THERAPEUTICS LTD	$7.30	2.38%	-2.80%	-3.95%	-3.57%	-0.41%	47.47%	-84.81%	-98.69%	-98.56%	$17.40	$2.86	58.05%	155.24%	1.09	107,000	4.90%
DOMH	DOMINARI HOLDINGS INC	$3.16	7.85%	8.59%	-5.67%	-30.85%	-52.91%	-41.70%	-5.11%	-84.11%	-97.65%	$8.40	$2.76	62.38%	14.49%	1.27	663,000	920.00%
SLN	SILENCE THERAPEUTICS PLC	$5.47	5.19%	-17.50%	2.24%	-11.77%	9.40%	51.10%	-34.10%	-76.74%	N/A	$7.91	$1.97	30.85%	177.66%	0.63	478,000	-28.97%
RLAY	RELAY THERAPEUTICS INC	$9.60	1.69%	-3.32%	4.12%	12.15%	119.18%	224.32%	-37.98%	-73.01%	N/A	$11.49	$1.78	16.45%	440.85%	1.79	1,499,000	-27.20%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$27.59	1.81%	-0.93%	-2.13%	-27.64%	2.03%	-16.37%	-33.52%	-7.26%	N/A	$40.87	$25.52	32.49%	8.11%	0.83	536,000	-49.34%
RCUS	ARCUS BIOSCIENCES INC	$21.46	5.98%	-3.38%	5.87%	-7.06%	73.48%	155.48%	21.59%	-35.81%	N/A	$26.40	$6.50	18.71%	230.15%	1.56	847,000	-41.79%
PLYX	POLARYX THERAPEUTICS INC	$6.28	-2.48%	13.56%	126.71%	N/A	N/A	N/A	N/A	N/A	N/A	$48.91	$2.20	87.16%	185.45%	-0.36	229,000	-72.34%
NRXS	NEURAXIS INC	$7.51	6.52%	7.44%	42.23%	91.58%	173.09%	242.92%	N/A	N/A	N/A	$7.97	$1.33	5.77%	464.66%	1.02	181,000	66.06%
INSM	INSMED INC	$148.31	6.59%	3.93%	-0.20%	-16.62%	9.38%	88.83%	760.27%	330.26%	1,186.30%	$212.75	$60.40	30.29%	145.55%	1.02	1,914,000	-29.55%
IVVD	INVIVYD INC	$1.56	9.09%	3.31%	-8.77%	-42.01%	36.84%	136.36%	11.83%	N/A	N/A	$3.07	$0.46	49.19%	239.13%	1.31	2,116,000	72.73%
TSHA	TAYSHA GENE THERAPIES INC	$4.58	10.90%	2.92%	-1.93%	-21.44%	49.67%	158.76%	558.99%	-79.05%	N/A	$6.02	$1.05	23.92%	336.19%	1.82	3,016,000	-46.46%
BEAM	BEAM THERAPEUTICS INC	$23.12	-3.47%	-8.69%	-21.92%	-17.37%	0.13%	-0.43%	-24.30%	-72.26%	N/A	$36.44	$13.53	36.55%	70.94%	2.06	5,218,000	229.42%
ARWR	ARROWHEAD PHARMACEUTICALS INC	$60.77	8.00%	7.16%	-1.37%	-13.38%	91.95%	312.56%	148.75%	-6.81%	1,259.51%	$76.76	$9.57	20.83%	535.01%	1.64	2,732,000	46.25%
SEPN	SEPTERNA INC	$24.21	3.28%	0.41%	-19.27%	-15.41%	44.54%	296.89%	N/A	N/A	N/A	$32.63	$4.66	25.80%	419.53%	1.35	134,000	-18.29%
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$3.11	0.97%	1.97%	-4.60%	-4.89%	15.61%	35.22%	-77.41%	-90.84%	N/A	$4.11	$1.67	24.24%	86.79%	1.10	1,292,000	-16.48%
ADAG	ADAGENE INC	$4.07	12.74%	3.30%	28.80%	128.65%	101.49%	148.17%	197.08%	-77.02%	N/A	$4.58	$1.30	11.12%	213.08%	0.34	160,000	138.81%
PTGX	PROTAGONIST THERAPEUTICS INC	$104.31	3.90%	7.44%	19.76%	17.49%	61.22%	104.33%	379.37%	265.74%	N/A	$105.69	$39.60	1.31%	163.41%	1.01	799,000	-13.34%
KALV	KALVISTA PHARMACEUTICALS INC	$17.14	4.13%	10.65%	8.76%	12.99%	41.71%	37.12%	159.30%	-40.73%	97.72%	$19.00	$9.24	9.79%	85.60%	0.84	1,720,000	146.42%
ANL	ADLAI NORTYE LTD	$7.12	1.86%	-3.91%	-26.67%	334.15%	300.00%	217.86%	N/A	N/A	N/A	$12.09	$0.88	41.11%	710.01%	0.55	147,000	81.48%
OBIO	ORCHESTRA BIOMED HOLDINGS INC	$4.57	-1.93%	1.33%	5.06%	5.79%	88.07%	2.93%	-70.03%	-55.24%	N/A	$5.42	$2.20	15.74%	107.73%	0.92	200,000	-23.66%
VRCA	VERRICA PHARMACEUTICALS INC	$4.62	3.13%	-19.09%	-17.06%	-43.38%	12.96%	-3.08%	-92.84%	-96.60%	N/A	$9.82	$3.28	52.96%	40.85%	0.96	65,000	-53.90%
LEGN	LEGEND BIOTECH CORP	$17.60	2.98%	-3.35%	-10.75%	-21.88%	-46.37%	-49.79%	-62.53%	-37.79%	N/A	$45.30	$16.24	61.15%	8.37%	0.70	1,102,000	24.94%
CAMP	CAMP4 THERAPEUTICS CORP	$4.75	4.86%	-10.88%	6.74%	-20.30%	58.33%	-7.77%	N/A	N/A	N/A	$7.75	$1.31	38.71%	263.98%	1.44	105,000	3.96%
ERAS	ERASCA INC	$15.99	9.00%	18.44%	18.80%	359.48%	783.43%	980.41%	473.12%	N/A	N/A	$16.41	$1.01	2.53%	1,483.17%	1.35	5,583,000	41.38%
AKTS	AKTIS ONCOLOGY INC	$18.64	0.05%	1.97%	-4.41%	N/A	N/A	N/A	N/A	N/A	N/A	$29.16	$16.80	36.08%	10.95%	1.97	270,000	-38.64%
PHAT	PHATHOM PHARMACEUTICALS INC	$10.47	4.08%	-4.47%	-15.02%	-40.38%	-10.21%	63.85%	56.74%	-74.62%	N/A	$18.31	$2.21	42.82%	373.76%	1.42	837,000	-30.08%
ACIU	AC IMMUNE SA	$2.94	2.80%	-4.85%	6.52%	-6.07%	1.03%	48.48%	31.84%	-62.11%	N/A	$4.00	$1.43	26.50%	105.59%	1.09	129,000	18.35%
SLS	SELLAS LIFE SCIENCES GROUP INC	$5.30	6.11%	7.07%	16.48%	84.67%	229.19%	334.43%	343.51%	-38.23%	-99.98%	$6.14	$0.95	13.68%	456.72%	1.10	5,601,000	-32.87%
CCCC	C4 THERAPEUTICS INC	$2.69	7.60%	0.00%	-2.89%	26.89%	22.83%	23.39%	-22.25%	-93.24%	N/A	$3.82	$1.09	29.58%	147.93%	1.99	1,344,000	-17.19%
GLPG	GALAPAGOS NV	$30.64	2.82%	-4.76%	-9.94%	-7.24%	-6.18%	20.02%	-17.79%	-59.76%	-25.50%	$37.78	$22.59	18.90%	35.63%	0.59	381,000	-38.35%
ALLO	ALLOGENE THERAPEUTICS INC	$2.33	5.43%	8.37%	-7.91%	68.84%	94.17%	45.63%	-53.68%	-93.24%	N/A	$2.80	$0.86	16.79%	170.30%	1.61	4,403,000	-0.43%
CDXS	CODEXIS INC	$1.75	4.79%	19.05%	56.25%	7.36%	-27.08%	-40.48%	-54.31%	-91.67%	-45.48%	$3.87	$0.96	54.78%	82.67%	1.95	1,155,000	-16.24%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Mar 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Veracyte (NASDAQ:VCYT)

Veracyte (NASDAQ:VCYT) is the #1 top biotech stock out of 605 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Veracyte (NASDAQ:VCYT) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Veracyte (NASDAQ:VCYT) has a Due Diligence Score of 59, which is 34 points higher than the biotech industry average of 25.

VCYT passed 19 out of 33 due diligence checks and has strong fundamentals. Veracyte has seen its stock lose -2.67% over the past year, overperforming other biotech stocks by 32 percentage points.

Veracyte has an average 1 year price target of $45.17, an upside of 37.75% from Veracyte's current stock price of $32.79.

Veracyte stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Veracyte, 50% have issued a Strong Buy rating, 16.67% have issued a Buy, 16.67% have issued a hold, while 0% have issued a Sell rating, and 16.67% have issued a Strong Sell.

2. Pharming Group Nv (NASDAQ:PHAR)

Pharming Group Nv (NASDAQ:PHAR) is the #2 top biotech stock out of 605 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pharming Group Nv (NASDAQ:PHAR) is: Value: B, Growth: B, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: C.

Pharming Group Nv (NASDAQ:PHAR) has a Due Diligence Score of 30, which is 5 points higher than the biotech industry average of 25.

PHAR passed 9 out of 33 due diligence checks and has average fundamentals. Pharming Group Nv has seen its stock return 86.1% over the past year, overperforming other biotech stocks by 121 percentage points.

Pharming Group Nv has an average 1 year price target of $39.00, an upside of 140.3% from Pharming Group Nv's current stock price of $16.23.

Pharming Group Nv stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Pharming Group Nv, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #3 top biotech stock out of 605 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: C, Financials: B, and AI: B.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 16, which is -9 points lower than the biotech industry average of 25. Although this number is below the industry average, our proven quant model rates JAZZ as a "A".

JAZZ passed 5 out of 33 due diligence checks and has weak fundamentals. Jazz Pharmaceuticals has seen its stock return 39.8% over the past year, overperforming other biotech stocks by 74 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $223.91, an upside of 18.42% from Jazz Pharmaceuticals's current stock price of $189.08.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Jazz Pharmaceuticals, 63.64% have issued a Strong Buy rating, 27.27% have issued a Buy, 9.09% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 6 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

Novabay Pharmaceuticals (NYSEMKT:NBY) has an annual dividend yield of 281.69%, which is 242 percentage points higher than the biotech industry average of 39.49%.

Novabay Pharmaceuticals's dividend payout ratio of -105.3% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 21.04%, which is -18 percentage points lower than the biotech industry average of 39.49%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 7.14%, which is -32 percentage points lower than the biotech industry average of 39.49%.

Oramed Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 2.92% in the last day, and up 1.12% over the last week. Sarepta Therapeutics was the among the top gainers in the biotechnology industry, gaining 34.98% yesterday.

Sarepta Therapeutics shares are trading higher after the company announced that early results from Phase 1/2 studies of SRP-1001 for facioscapulohumeral muscular dystrophy type 1 and SRP-1003 for myotonic dystrophy type 1. Also, the company generated proof-of-concept data for SRP-1001 and SRP-1003.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -16.37% in the past year. It has overperformed other stocks in the biotech industry by 18 percentage points.

2. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Incyte's stock has gained 48.57% in the past year. It has overperformed other stocks in the biotech industry by 83 percentage points.

3. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Exelixis's stock has gained 13.46% in the past year. It has overperformed other stocks in the biotech industry by 48 percentage points.

Are biotech stocks a good buy now?

63.68% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 67.6% over the next year.

2.4% of biotech stocks have a Zen Rating of A (Strong Buy), 4.37% of biotech stocks are rated B (Buy), 47.38% are rated C (Hold), 34.28% are rated D (Sell), and 11.57% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 25.57x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Veracyte (NASDAQ:VCYT)

2. Pharming Group Nv (NASDAQ:PHAR)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Incyte (NASDAQ:INCY)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Veracyte (NASDAQ:VCYT)

2. Pharming Group Nv (NASDAQ:PHAR)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Incyte (NASDAQ:INCY)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.